Clearside Biomedical GAAP EPS of -$0.11 in-line, revenue of $2.3M beats by $2.1M

Stock Information for Clearside Biomedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Clearside Biomedical Inc.

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.